 | • レポートコード：QYR2104Z4441 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、爪囲炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン、その他）、用途別市場規模（病院、診療所、皮膚科センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・爪囲炎治療薬の市場動向 ・企業の競争状況、市場シェア ・爪囲炎治療薬の種類別市場規模（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン、その他） ・爪囲炎治療薬の用途別市場規模（病院、診療所、皮膚科センター、その他） ・爪囲炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・爪囲炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・爪囲炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・爪囲炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・爪囲炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Teva Pharmaceutical、Eli Lilly、Fougera Pharmaceuticals、Taro Pharmaceutical Industries、Glenmark Generics、Jonakayem Pharma Formulation） ・結論 |
Paronychia usually happens when the skin around an individual’s nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.
The Americas account for a major share in the global paronychia treatment market owing to the increasing prevalence of acute paronychia, chronic paronychia, candidal paronychia, and pyogenic paronychia.
Market Analysis and Insights: Global Paronychia Drugs Market
The global Paronychia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paronychia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paronychia Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paronychia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paronychia Drugs market.
Global Paronychia Drugs Scope and Market Size
Paronychia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paronychia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
Others
Segment by Application
Hospitals
Clinics
Dermatology Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Teva Pharmaceutical
Eli Lilly
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
Glenmark Generics
Jonakayem Pharma Formulation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paronychia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mupirocin Ointment
1.2.3 Fusidic Acid Ointment
1.2.4 Gentamicin Ointment
1.2.5 Dicloxacillin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Paronychia Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Dermatology Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Paronychia Drugs Market Perspective (2016-2027)
2.2 Paronychia Drugs Growth Trends by Regions
2.2.1 Paronychia Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paronychia Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Paronychia Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Paronychia Drugs Industry Dynamic
2.3.1 Paronychia Drugs Market Trends
2.3.2 Paronychia Drugs Market Drivers
2.3.3 Paronychia Drugs Market Challenges
2.3.4 Paronychia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paronychia Drugs Players by Revenue
3.1.1 Global Top Paronychia Drugs Players by Revenue (2016-2021)
3.1.2 Global Paronychia Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Paronychia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paronychia Drugs Revenue
3.4 Global Paronychia Drugs Market Concentration Ratio
3.4.1 Global Paronychia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paronychia Drugs Revenue in 2020
3.5 Paronychia Drugs Key Players Head office and Area Served
3.6 Key Players Paronychia Drugs Product Solution and Service
3.7 Date of Enter into Paronychia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paronychia Drugs Breakdown Data by Type
4.1 Global Paronychia Drugs Historic Market Size by Type (2016-2021)
4.2 Global Paronychia Drugs Forecasted Market Size by Type (2022-2027)
5 Paronychia Drugs Breakdown Data by Application
5.1 Global Paronychia Drugs Historic Market Size by Application (2016-2021)
5.2 Global Paronychia Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Paronychia Drugs Market Size (2016-2027)
6.2 North America Paronychia Drugs Market Size by Type
6.2.1 North America Paronychia Drugs Market Size by Type (2016-2021)
6.2.2 North America Paronychia Drugs Market Size by Type (2022-2027)
6.2.3 North America Paronychia Drugs Market Size by Type (2016-2027)
6.3 North America Paronychia Drugs Market Size by Application
6.3.1 North America Paronychia Drugs Market Size by Application (2016-2021)
6.3.2 North America Paronychia Drugs Market Size by Application (2022-2027)
6.3.3 North America Paronychia Drugs Market Size by Application (2016-2027)
6.4 North America Paronychia Drugs Market Size by Country
6.4.1 North America Paronychia Drugs Market Size by Country (2016-2021)
6.4.2 North America Paronychia Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Paronychia Drugs Market Size (2016-2027)
7.2 Europe Paronychia Drugs Market Size by Type
7.2.1 Europe Paronychia Drugs Market Size by Type (2016-2021)
7.2.2 Europe Paronychia Drugs Market Size by Type (2022-2027)
7.2.3 Europe Paronychia Drugs Market Size by Type (2016-2027)
7.3 Europe Paronychia Drugs Market Size by Application
7.3.1 Europe Paronychia Drugs Market Size by Application (2016-2021)
7.3.2 Europe Paronychia Drugs Market Size by Application (2022-2027)
7.3.3 Europe Paronychia Drugs Market Size by Application (2016-2027)
7.4 Europe Paronychia Drugs Market Size by Country
7.4.1 Europe Paronychia Drugs Market Size by Country (2016-2021)
7.4.2 Europe Paronychia Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Paronychia Drugs Market Size (2016-2027)
8.2 Asia-Pacific Paronychia Drugs Market Size by Type
8.2.1 Asia-Pacific Paronychia Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paronychia Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paronychia Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Paronychia Drugs Market Size by Application
8.3.1 Asia-Pacific Paronychia Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paronychia Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paronychia Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Paronychia Drugs Market Size by Region
8.4.1 Asia-Pacific Paronychia Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paronychia Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Paronychia Drugs Market Size (2016-2027)
9.2 Latin America Paronychia Drugs Market Size by Type
9.2.1 Latin America Paronychia Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Paronychia Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Paronychia Drugs Market Size by Type (2016-2027)
9.3 Latin America Paronychia Drugs Market Size by Application
9.3.1 Latin America Paronychia Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Paronychia Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Paronychia Drugs Market Size by Application (2016-2027)
9.4 Latin America Paronychia Drugs Market Size by Country
9.4.1 Latin America Paronychia Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Paronychia Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paronychia Drugs Market Size (2016-2027)
10.2 Middle East & Africa Paronychia Drugs Market Size by Type
10.2.1 Middle East & Africa Paronychia Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paronychia Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paronychia Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Paronychia Drugs Market Size by Application
10.3.1 Middle East & Africa Paronychia Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paronychia Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paronychia Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Paronychia Drugs Market Size by Country
10.4.1 Middle East & Africa Paronychia Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paronychia Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Paronychia Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Paronychia Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Paronychia Drugs Introduction
11.2.4 Teva Pharmaceutical Revenue in Paronychia Drugs Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Paronychia Drugs Introduction
11.3.4 Eli Lilly Revenue in Paronychia Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Fougera Pharmaceuticals
11.4.1 Fougera Pharmaceuticals Company Details
11.4.2 Fougera Pharmaceuticals Business Overview
11.4.3 Fougera Pharmaceuticals Paronychia Drugs Introduction
11.4.4 Fougera Pharmaceuticals Revenue in Paronychia Drugs Business (2016-2021)
11.4.5 Fougera Pharmaceuticals Recent Development
11.5 Taro Pharmaceutical Industries
11.5.1 Taro Pharmaceutical Industries Company Details
11.5.2 Taro Pharmaceutical Industries Business Overview
11.5.3 Taro Pharmaceutical Industries Paronychia Drugs Introduction
11.5.4 Taro Pharmaceutical Industries Revenue in Paronychia Drugs Business (2016-2021)
11.5.5 Taro Pharmaceutical Industries Recent Development
11.6 Glenmark Generics
11.6.1 Glenmark Generics Company Details
11.6.2 Glenmark Generics Business Overview
11.6.3 Glenmark Generics Paronychia Drugs Introduction
11.6.4 Glenmark Generics Revenue in Paronychia Drugs Business (2016-2021)
11.6.5 Glenmark Generics Recent Development
11.7 Jonakayem Pharma Formulation
11.7.1 Jonakayem Pharma Formulation Company Details
11.7.2 Jonakayem Pharma Formulation Business Overview
11.7.3 Jonakayem Pharma Formulation Paronychia Drugs Introduction
11.7.4 Jonakayem Pharma Formulation Revenue in Paronychia Drugs Business (2016-2021)
11.7.5 Jonakayem Pharma Formulation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Paronychia Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mupirocin Ointment
Table 3. Key Players of Fusidic Acid Ointment
Table 4. Key Players of Gentamicin Ointment
Table 5. Key Players of Dicloxacillin
Table 6. Key Players of Others
Table 7. Global Paronychia Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Paronychia Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Paronychia Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Paronychia Drugs Market Share by Regions (2016-2021)
Table 11. Global Paronychia Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Paronychia Drugs Market Share by Regions (2022-2027)
Table 13. Paronychia Drugs Market Trends
Table 14. Paronychia Drugs Market Drivers
Table 15. Paronychia Drugs Market Challenges
Table 16. Paronychia Drugs Market Restraints
Table 17. Global Paronychia Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Paronychia Drugs Market Share by Players (2016-2021)
Table 19. Global Top Paronychia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Drugs as of 2020)
Table 20. Ranking of Global Top Paronychia Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Paronychia Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Paronychia Drugs Product Solution and Service
Table 24. Date of Enter into Paronychia Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Paronychia Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Paronychia Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Paronychia Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Paronychia Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Paronychia Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Paronychia Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Paronychia Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Paronychia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Paronychia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Paronychia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Paronychia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Paronychia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Paronychia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Paronychia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Paronychia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Paronychia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Paronychia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Paronychia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Paronychia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Paronychia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Paronychia Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Paronychia Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Paronychia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Paronychia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Paronychia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Paronychia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Paronychia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Paronychia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Paronychia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Paronychia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Paronychia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Paronychia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Paronychia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Paronychia Drugs Product
Table 67. GlaxoSmithKline Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Teva Pharmaceutical Company Details
Table 70. Teva Pharmaceutical Business Overview
Table 71. Teva Pharmaceutical Paronychia Drugs Product
Table 72. Teva Pharmaceutical Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 73. Teva Pharmaceutical Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Paronychia Drugs Product
Table 77. Eli Lilly Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly Recent Development
Table 79. Fougera Pharmaceuticals Company Details
Table 80. Fougera Pharmaceuticals Business Overview
Table 81. Fougera Pharmaceuticals Paronychia Drugs Product
Table 82. Fougera Pharmaceuticals Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 83. Fougera Pharmaceuticals Recent Development
Table 84. Taro Pharmaceutical Industries Company Details
Table 85. Taro Pharmaceutical Industries Business Overview
Table 86. Taro Pharmaceutical Industries Paronychia Drugs Product
Table 87. Taro Pharmaceutical Industries Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 88. Taro Pharmaceutical Industries Recent Development
Table 89. Glenmark Generics Company Details
Table 90. Glenmark Generics Business Overview
Table 91. Glenmark Generics Paronychia Drugs Product
Table 92. Glenmark Generics Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 93. Glenmark Generics Recent Development
Table 94. Jonakayem Pharma Formulation Company Details
Table 95. Jonakayem Pharma Formulation Business Overview
Table 96. Jonakayem Pharma Formulation Paronychia Drugs Product
Table 97. Jonakayem Pharma Formulation Revenue in Paronychia Drugs Business (2016-2021) & (US$ Million)
Table 98. Jonakayem Pharma Formulation Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paronychia Drugs Market Share by Type: 2020 VS 2027
Figure 2. Mupirocin Ointment Features
Figure 3. Fusidic Acid Ointment Features
Figure 4. Gentamicin Ointment Features
Figure 5. Dicloxacillin Features
Figure 6. Others Features
Figure 7. Global Paronychia Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Dermatology Center Case Studies
Figure 11. Others Case Studies
Figure 12. Paronychia Drugs Report Years Considered
Figure 13. Global Paronychia Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Paronychia Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Paronychia Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Paronychia Drugs Market Share by Regions (2022-2027)
Figure 17. Global Paronychia Drugs Market Share by Players in 2020
Figure 18. Global Top Paronychia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Paronychia Drugs Revenue in 2020
Figure 20. Global Paronychia Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Paronychia Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Paronychia Drugs Market Share by Type (2016-2027)
Figure 24. North America Paronychia Drugs Market Share by Application (2016-2027)
Figure 25. North America Paronychia Drugs Market Share by Country (2016-2027)
Figure 26. United States Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Paronychia Drugs Market Share by Type (2016-2027)
Figure 30. Europe Paronychia Drugs Market Share by Application (2016-2027)
Figure 31. Europe Paronychia Drugs Market Share by Country (2016-2027)
Figure 32. Germany Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Paronychia Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Paronychia Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Paronychia Drugs Market Share by Region (2016-2027)
Figure 42. China Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Paronychia Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Paronychia Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Paronychia Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Paronychia Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Paronychia Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Paronychia Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Paronychia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 64. Fougera Pharmaceuticals Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 65. Taro Pharmaceutical Industries Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 66. Glenmark Generics Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 67. Jonakayem Pharma Formulation Revenue Growth Rate in Paronychia Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の爪囲炎治療市場規模・現状・予測（2021年-2027年） Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia). When no pus is present, warm soak…- 世界のトリアムシノロンアセトニド軟膏市場 2021：企業別、地域別、種類・用途別 The Triamcinolone Acetonide Ointment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のタクロリムス軟膏市場 2021：企業別、地域別、種類・用途別 The Tacrolimus Ointment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のトリアムシノロン軟膏クロロフルオロカーボン市場 2021：企業別、地域別、種類・用途別 The Triamcinolone Ointment Chlorofluorocarbons market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の抗真菌薬市場規模・現状・予測（2021年-2027年） Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails. Market Analysis and Insights: Global Anti-fungal Drugs Market The global Anti-fungal Drugs market size is projected to reach US$ 2048.7 million by 2026, from US$ 1728.4 million in 2019, at a C…